Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Curr Opin Rheumatol. 2021 Mar 1;33(2):135–144. doi: 10.1097/BOR.0000000000000779

Figure 2:

Figure 2:

Persistent Premature Mortality Among Patients with Gout Remains Higher than Premature Mortality in Rheumatoid Arthritis in Recent Decades

Panel (a) compares the cumulative incidence of death from 1999 to 2006 (red lines) to that from 2007 to 2014 (blue lines) among patients with gout (solid lines) and without gout (dotted lines), with the difference between the solid and dotted lines remaining unchanged during the two time periods, indicating persistent premature mortality. Conversely, panel (b) compares the cumulative incidence of death from 1999 to 2006 (red lines) to that from 2007 to 2014 (blue lines) among patients with RA (solid lines) and without RA (dotted lines). The difference in mortality between the two blue lines is substantially smaller than that between the two red lines, indicating an improvement in the mortality gap among patients with RA in the latter time period.

Adapted from: Fisher et al. Ann Rheum Dis 2017 & Zhang et al. Ann Rheum Dis 2017.

RA = rheumatoid arthritis